Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Clinical Reference Laboratory Molecular Diagnostic Services Market Overview
Clinical reference laboratory molecular diagnostic services refer to the analysis of biological samples (such as blood, tissue, etc.) of patients through molecular biology techniques (such as PCR, gene sequencing, etc.) to detect genetic material (DNA, RNA) changes related to diseases, thereby providing scientific basis for disease diagnosis, treatment, and prognosis. Its application areas include disease diagnosis, drug development, personalized medicine, forensic identification, etc.
Key Insights & Strategic Takeaways Driving Market Outlook
(1) Global Clinical Reference Laboratory Molecular Diagnostic Services market size (sales volume & revenue), history data from 2020 - 2025, and forecast data from {2025 to 2031.
(2) Global Clinical Reference Laboratory Molecular Diagnostic Services market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.
(3) China Clinical Reference Laboratory Molecular Diagnostic Services market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.
(4) Global Clinical Reference Laboratory Molecular Diagnostic Services segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.
(5) Global Clinical Reference Laboratory Molecular Diagnostic Services segment by Type, and by Application, and regional segment by Type, and by Application.
(6) Global major production regions of Clinical Reference Laboratory Molecular Diagnostic Services , capacity, production and trends.
(7) Clinical Reference Laboratory Molecular Diagnostic Services industry supply chain, upstream, midstream, and downstream analysis.
In-Depth Assessment of Market Segmentation by Geographic Region
➤ North America (United States, Canada, and Mexico)
➤ Europe (UK, Germany, France, Russia, and Italy)
➤ Asia-Pacific (China, Korea, Japan, India, and Southeast Asia)
➤ South America (Brazil, Colombia, Argentina, etc.)
➤ The Middle East and Africa (Saudi Arabia, UAE, Nigeria, Egypt, and South Africa)
Segmentation by Product Type: Analytical Breakdown and Market Relevance
This section presents a comprehensive analysis of the market based on product type, highlighting segment-wise performance indicators, emerging trends, and their strategic implications within the overall industry landscape.
- Disease Diagnosis
- Drug Development
- Personalized Healthcare
- Medicolegal Expertise
- Others
Market Segmentation by Application
Markets are categorized based on specific application areas, offering insight into usage trends and consumer preferences. This segmentation helps businesses tailor products, services, and strategies to align with diverse industry needs and customer demands.
- Nucleic Acid Amplification Testing
- Nucleic Acid Hybridization Testing
- Gene Sequencing
- Gene Chip Technology
- Others
Market Segmentation by Key Players
This report examines the competitive landscape by categorizing market participants based on their roles, influence, and strategic positioning. Understanding player segmentation helps identify industry leaders, emerging competitors, and collaboration opportunities within the market.
- Quest Diagnostics
- Eurofins Scientific
- Mayo Clinic Laboratories
- Genomic Health
- Clinical Reference Laboratory
- Molecular Pathology Laboratory Network
- Opko Health
- NantHealth
- ARUP Laboratories
- Viant Medical
- Sonic Healthcare
- Fulgent Genetics
- Laboratory Corporation of America Holdings
- BGI Genomics
- Daan Gene
- Guangdong Hybribio Biotech
- Jiangsu Bioperfectus Technologies
- Maccura Biotechnology
- Guangzhou Wondfo Biotech
- GoBroad Healthcare
1 Market Overview
1.1 Product Overview and Scope of Clinical Reference Laboratory Molecular Diagnostic Services
1.2 Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size and Forecast
1.3 China Clinical Reference Laboratory Molecular Diagnostic Services Market Size and Forecast
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Clinical Reference Laboratory Molecular Diagnostic Services Share in Global Market, 2020-2031
1.4.2 Clinical Reference Laboratory Molecular Diagnostic Services Market Size: China VS Global, 2020-2031
1.5 Clinical Reference Laboratory Molecular Diagnostic Services Market Dynamics
1.5.1 Clinical Reference Laboratory Molecular Diagnostic Services Market Drivers
1.5.2 Clinical Reference Laboratory Molecular Diagnostic Services Market Restraints
1.5.3 Clinical Reference Laboratory Molecular Diagnostic Services Industry Trends
1.5.4 Clinical Reference Laboratory Molecular Diagnostic Services Industry Policy
2 Competitive Landscape by Company
2.1 Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue by Company, 2020-2025
2.2 Global Clinical Reference Laboratory Molecular Diagnostic Services Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Clinical Reference Laboratory Molecular Diagnostic Services Concentration Ratio
2.4 Global Clinical Reference Laboratory Molecular Diagnostic Services Mergers & Acquisitions, Expansion Plans
2.5 Global Clinical Reference Laboratory Molecular Diagnostic Services Manufacturers Product Type
2.6 Global Geographic Distribution of Clinical Reference Laboratory Molecular Diagnostic Services Companies
3 China Competitive Situation by Company
3.1 China Clinical Reference Laboratory Molecular Diagnostic Services Revenue by Company, 2020-2025
3.2 China Clinical Reference Laboratory Molecular Diagnostic Services Clinical Reference Laboratory Molecular Diagnostic Services Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.3 China Clinical Reference Laboratory Molecular Diagnostic Services Market, Revenue Percentage of Local Players VS Foreign Players (2020-2031)
4 Industry Chain Analysis
4.1 Clinical Reference Laboratory Molecular Diagnostic Services Industry Chain
4.2 Clinical Reference Laboratory Molecular Diagnostic Services Upstream Analysis
4.3 Clinical Reference Laboratory Molecular Diagnostic Services Midstream Analysis
4.4 Clinical Reference Laboratory Molecular Diagnostic Services Downstream Analysis
5 Sights by Type
5.1 Clinical Reference Laboratory Molecular Diagnostic Services Classification
5.1.1 Nucleic Acid Amplification Testing
5.1.2 Nucleic Acid Hybridization Testing
5.1.3 Gene Sequencing
5.1.4 Gene Chip Technology
5.1.5 Others
5.2 by Type, Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size & CAGR, 2020 VS 2024 VS 2031
5.3 by Type, Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size, 2020-2031
6 Sights by Application
6.1 Clinical Reference Laboratory Molecular Diagnostic Services Segment by Application
6.1.1 Disease Diagnosis
6.1.2 Drug Development
6.1.3 Personalized Healthcare
6.1.4 Medicolegal Expertise
6.1.5 Others
6.2 by Application, Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Application, Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size, 2020-2031
7 Sights by Region
7.1 By Region, Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size, 2020 VS 2024 VS 2031
7.2 By Region, Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size, 2020-2031
7.3 North America
7.3.1 North America Clinical Reference Laboratory Molecular Diagnostic Services Market Size & Forecasts, 2020-2031
7.3.2 By Country, North America Clinical Reference Laboratory Molecular Diagnostic Services Market Size Market Share
7.4 Europe
7.4.1 Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Size & Forecasts, 2020-2031
7.4.2 By Country, Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Clinical Reference Laboratory Molecular Diagnostic Services Market Size & Forecasts, 2020-2031
7.5.2 By Country/Region, Asia Pacific Clinical Reference Laboratory Molecular Diagnostic Services Market Size Market Share
7.6 South America
7.6.1 South America Clinical Reference Laboratory Molecular Diagnostic Services Market Size & Forecasts, 2020-2031
7.6.2 By Country, South America Clinical Reference Laboratory Molecular Diagnostic Services Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size & CAGR,2020 VS 2024 VS 2031
8.2 By Country, Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size, 2020-2031
8.3 United States
8.3.1 United States Clinical Reference Laboratory Molecular Diagnostic Services Market Size, 2020-2031
8.3.2 By Company, United States Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024
8.3.3 by Type, United States Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
8.3.4 by Application, United States Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
8.4 Europe
8.4.1 Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Size, 2020-2031
8.4.2 By Company, Europe Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024
8.4.3 by Type, Europe Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
8.4.4 by Application, Europe Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
8.5 China
8.5.1 China Clinical Reference Laboratory Molecular Diagnostic Services Market Size, 2020-2031
8.5.2 By Company, China Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024
8.5.3 by Type, China Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
8.5.4 by Application, China Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
8.6 Japan
8.6.1 Japan Clinical Reference Laboratory Molecular Diagnostic Services Market Size, 2020-2031
8.6.2 By Company, Japan Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024
8.6.3 by Type, Japan Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
8.6.4 by Application, Japan Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
8.7 South Korea
8.7.1 South Korea Clinical Reference Laboratory Molecular Diagnostic Services Market Size, 2020-2031
8.7.2 By Company, South Korea Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024
8.7.3 by Type, South Korea Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
8.7.4 by Application, South Korea Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
8.8 Southeast Asia
8.8.1 Southeast Asia Clinical Reference Laboratory Molecular Diagnostic Services Market Size, 2020-2031
8.8.2 By Company, Southeast Asia Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024
8.8.3 by Type, Southeast Asia Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
8.8.4 by Application, Southeast Asia Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
8.9 India
8.9.1 India Clinical Reference Laboratory Molecular Diagnostic Services Market Size, 2020-2031
8.9.2 By Company, India Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024
8.9.3 by Type, India Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
8.9.4 by Application, India Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
8.10 Middle East & Africa
8.10.1 Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Market Size, 2020-2031
8.10.2 By Company, Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024
8.10.3 by Type, Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
8.10.4 by Application, Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
9 Company Profile
9.1 Quest Diagnostics
9.1.1 Quest Diagnostics Company Information, Head Office, Market Area, and Industry Position
9.1.2 Quest Diagnostics Company Profile and Main Business
9.1.3 Quest Diagnostics Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
9.1.4 Quest Diagnostics Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, 2020-2025
9.1.5 Quest Diagnostics Recent Developments
9.2 Eurofins Scientific
9.2.1 Eurofins Scientific Company Information, Head Office, Market Area, and Industry Position
9.2.2 Eurofins Scientific Company Profile and Main Business
9.2.3 Eurofins Scientific Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
9.2.4 Eurofins Scientific Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, 2020-2025
9.2.5 Eurofins Scientific Recent Developments
9.3 Mayo Clinic Laboratories
9.3.1 Mayo Clinic Laboratories Company Information, Head Office, Market Area, and Industry Position
9.3.2 Mayo Clinic Laboratories Company Profile and Main Business
9.3.3 Mayo Clinic Laboratories Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
9.3.4 Mayo Clinic Laboratories Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, 2020-2025
9.3.5 Mayo Clinic Laboratories Recent Developments
9.4 Genomic Health
9.4.1 Genomic Health Company Information, Head Office, Market Area, and Industry Position
9.4.2 Genomic Health Company Profile and Main Business
9.4.3 Genomic Health Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
9.4.4 Genomic Health Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, 2020-2025
9.4.5 Genomic Health Recent Developments
9.5 Clinical Reference Laboratory
9.5.1 Clinical Reference Laboratory Company Information, Head Office, Market Area, and Industry Position
9.5.2 Clinical Reference Laboratory Company Profile and Main Business
9.5.3 Clinical Reference Laboratory Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
9.5.4 Clinical Reference Laboratory Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, 2020-2025
9.5.5 Clinical Reference Laboratory Recent Developments
9.6 Molecular Pathology Laboratory Network
9.6.1 Molecular Pathology Laboratory Network Company Information, Head Office, Market Area, and Industry Position
9.6.2 Molecular Pathology Laboratory Network Company Profile and Main Business
9.6.3 Molecular Pathology Laboratory Network Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
9.6.4 Molecular Pathology Laboratory Network Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, 2020-2025
9.6.5 Molecular Pathology Laboratory Network Recent Developments
9.7 Opko Health
9.7.1 Opko Health Company Information, Head Office, Market Area, and Industry Position
9.7.2 Opko Health Company Profile and Main Business
9.7.3 Opko Health Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
9.7.4 Opko Health Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, 2020-2025
9.7.5 Opko Health Recent Developments
9.8 NantHealth
9.8.1 NantHealth Company Information, Head Office, Market Area, and Industry Position
9.8.2 NantHealth Company Profile and Main Business
9.8.3 NantHealth Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
9.8.4 NantHealth Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, 2020-2025
9.8.5 NantHealth Recent Developments
9.9 ARUP Laboratories
9.9.1 ARUP Laboratories Company Information, Head Office, Market Area, and Industry Position
9.9.2 ARUP Laboratories Company Profile and Main Business
9.9.3 ARUP Laboratories Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
9.9.4 ARUP Laboratories Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, 2020-2025
9.9.5 ARUP Laboratories Recent Developments
9.10 Viant Medical
9.10.1 Viant Medical Company Information, Head Office, Market Area, and Industry Position
9.10.2 Viant Medical Company Profile and Main Business
9.10.3 Viant Medical Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
9.10.4 Viant Medical Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, 2020-2025
9.10.5 Viant Medical Recent Developments
9.11 Sonic Healthcare
9.11.1 Sonic Healthcare Company Information, Head Office, Market Area, and Industry Position
9.11.2 Sonic Healthcare Company Profile and Main Business
9.11.3 Sonic Healthcare Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
9.11.4 Sonic Healthcare Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, 2020-2025
9.11.5 Sonic Healthcare Recent Developments
9.12 Fulgent Genetics
9.12.1 Fulgent Genetics Company Information, Head Office, Market Area, and Industry Position
9.12.2 Fulgent Genetics Company Profile and Main Business
9.12.3 Fulgent Genetics Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
9.12.4 Fulgent Genetics Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, 2020-2025
9.12.5 Fulgent Genetics Recent Developments
9.13 Laboratory Corporation of America Holdings
9.13.1 Laboratory Corporation of America Holdings Company Information, Head Office, Market Area, and Industry Position
9.13.2 Laboratory Corporation of America Holdings Company Profile and Main Business
9.13.3 Laboratory Corporation of America Holdings Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
9.13.4 Laboratory Corporation of America Holdings Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, 2020-2025
9.13.5 Laboratory Corporation of America Holdings Recent Developments
9.14 BGI Genomics
9.14.1 BGI Genomics Company Information, Head Office, Market Area, and Industry Position
9.14.2 BGI Genomics Company Profile and Main Business
9.14.3 BGI Genomics Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
9.14.4 BGI Genomics Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, 2020-2025
9.14.5 BGI Genomics Recent Developments
9.15 Daan Gene
9.15.1 Daan Gene Company Information, Head Office, Market Area, and Industry Position
9.15.2 Daan Gene Company Profile and Main Business
9.15.3 Daan Gene Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
9.15.4 Daan Gene Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, 2020-2025
9.15.5 Daan Gene Recent Developments
9.16 Guangdong Hybribio Biotech
9.16.1 Guangdong Hybribio Biotech Company Information, Head Office, Market Area, and Industry Position
9.16.2 Guangdong Hybribio Biotech Company Profile and Main Business
9.16.3 Guangdong Hybribio Biotech Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
9.16.4 Guangdong Hybribio Biotech Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, 2020-2025
9.16.5 Guangdong Hybribio Biotech Recent Developments
9.17 Jiangsu Bioperfectus Technologies
9.17.1 Jiangsu Bioperfectus Technologies Company Information, Head Office, Market Area, and Industry Position
9.17.2 Jiangsu Bioperfectus Technologies Company Profile and Main Business
9.17.3 Jiangsu Bioperfectus Technologies Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
9.17.4 Jiangsu Bioperfectus Technologies Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, 2020-2025
9.17.5 Jiangsu Bioperfectus Technologies Recent Developments
9.18 Maccura Biotechnology
9.18.1 Maccura Biotechnology Company Information, Head Office, Market Area, and Industry Position
9.18.2 Maccura Biotechnology Company Profile and Main Business
9.18.3 Maccura Biotechnology Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
9.18.4 Maccura Biotechnology Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, 2020-2025
9.18.5 Maccura Biotechnology Recent Developments
9.19 Guangzhou Wondfo Biotech
9.19.1 Guangzhou Wondfo Biotech Company Information, Head Office, Market Area, and Industry Position
9.19.2 Guangzhou Wondfo Biotech Company Profile and Main Business
9.19.3 Guangzhou Wondfo Biotech Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
9.19.4 Guangzhou Wondfo Biotech Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, 2020-2025
9.19.5 Guangzhou Wondfo Biotech Recent Developments
9.20 GoBroad Healthcare
9.20.1 GoBroad Healthcare Company Information, Head Office, Market Area, and Industry Position
9.20.2 GoBroad Healthcare Company Profile and Main Business
9.20.3 GoBroad Healthcare Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
9.20.4 GoBroad Healthcare Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, 2020-2025
9.20.5 GoBroad Healthcare Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables & Figures:
List of Tables
Table 1. Clinical Reference Laboratory Molecular Diagnostic Services Market Size & CAGR: China VS Global, 2020-2031, US$ Million
Table 2. Clinical Reference Laboratory Molecular Diagnostic Services Market Restraints
Table 3. Clinical Reference Laboratory Molecular Diagnostic Services Market Trends
Table 4. Clinical Reference Laboratory Molecular Diagnostic Services Industry Policy
Table 5. Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue by Company, 2020-2025, US$ million
Table 6. Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share by Company, 2020-2025
Table 7. Global Clinical Reference Laboratory Molecular Diagnostic Services Players Market Concentration Ratio (CR3 and HHI)
Table 8. Global Clinical Reference Laboratory Molecular Diagnostic Services Mergers & Acquisitions, Expansion Plans
Table 9. Global Clinical Reference Laboratory Molecular Diagnostic Services Manufacturers Product Type
Table 10. Global Headquarters and Manufacturing Base of Clinical Reference Laboratory Molecular Diagnostic Services Manufacturers
Table 11. China Clinical Reference Laboratory Molecular Diagnostic Services Revenue by Company, 2020-2025, US$ million
Table 12. China Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share by Company, 2020-2025
Table 13. Global Key Players of Clinical Reference Laboratory Molecular Diagnostic Services Upstream (Raw Materials)
Table 14. Global Clinical Reference Laboratory Molecular Diagnostic Services Typical Customers
Table 15. by Type, Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 16. by Application, Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 17. By Region, Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue, 2020 VS 2024 VS 2031, US$ Million
Table 18. By Region, Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue, 2020-2025, US$ Million
Table 19. By Region, Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue, 2020-2031, US$ Million
Table 20. By Country, Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue & CAGR,2020 VS 2024 VS 2031, US$ Million
Table 21. By Country, Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue, 2020-2025, US$ Million
Table 22. By Country, Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue, 2026-2031, US$ Million
Table 23. By Country, Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2020-2025
Table 24. By Country, Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2026-2031
Table 25. Quest Diagnostics Company Information, Head Office, Market Area, and Industry Position
Table 26. Quest Diagnostics Company Profile and Main Business
Table 27. Quest Diagnostics Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
Table 28. Quest Diagnostics Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 29. Quest Diagnostics Recent Developments
Table 30. Eurofins Scientific Company Information, Head Office, Market Area, and Industry Position
Table 31. Eurofins Scientific Company Profile and Main Business
Table 32. Eurofins Scientific Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
Table 33. Eurofins Scientific Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 34. Eurofins Scientific Recent Developments
Table 35. Mayo Clinic Laboratories Company Information, Head Office, Market Area, and Industry Position
Table 36. Mayo Clinic Laboratories Company Profile and Main Business
Table 37. Mayo Clinic Laboratories Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
Table 38. Mayo Clinic Laboratories Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 39. Mayo Clinic Laboratories Recent Developments
Table 40. Genomic Health Company Information, Head Office, Market Area, and Industry Position
Table 41. Genomic Health Company Profile and Main Business
Table 42. Genomic Health Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
Table 43. Genomic Health Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 44. Genomic Health Recent Developments
Table 45. Clinical Reference Laboratory Company Information, Head Office, Market Area, and Industry Position
Table 46. Clinical Reference Laboratory Company Profile and Main Business
Table 47. Clinical Reference Laboratory Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
Table 48. Clinical Reference Laboratory Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 49. Clinical Reference Laboratory Recent Developments
Table 50. Molecular Pathology Laboratory Network Company Information, Head Office, Market Area, and Industry Position
Table 51. Molecular Pathology Laboratory Network Company Profile and Main Business
Table 52. Molecular Pathology Laboratory Network Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
Table 53. Molecular Pathology Laboratory Network Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 54. Molecular Pathology Laboratory Network Recent Developments
Table 55. Opko Health Company Information, Head Office, Market Area, and Industry Position
Table 56. Opko Health Company Profile and Main Business
Table 57. Opko Health Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
Table 58. Opko Health Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 59. Opko Health Recent Developments
Table 60. NantHealth Company Information, Head Office, Market Area, and Industry Position
Table 61. NantHealth Company Profile and Main Business
Table 62. NantHealth Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
Table 63. NantHealth Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 64. NantHealth Recent Developments
Table 65. ARUP Laboratories Company Information, Head Office, Market Area, and Industry Position
Table 66. ARUP Laboratories Company Profile and Main Business
Table 67. ARUP Laboratories Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
Table 68. ARUP Laboratories Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 69. ARUP Laboratories Recent Developments
Table 70. Viant Medical Company Information, Head Office, Market Area, and Industry Position
Table 71. Viant Medical Company Profile and Main Business
Table 72. Viant Medical Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
Table 73. Viant Medical Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 74. Viant Medical Recent Developments
Table 75. Sonic Healthcare Company Information, Head Office, Market Area, and Industry Position
Table 76. Sonic Healthcare Company Profile and Main Business
Table 77. Sonic Healthcare Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
Table 78. Sonic Healthcare Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 79. Sonic Healthcare Recent Developments
Table 80. Fulgent Genetics Company Information, Head Office, Market Area, and Industry Position
Table 81. Fulgent Genetics Company Profile and Main Business
Table 82. Fulgent Genetics Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
Table 83. Fulgent Genetics Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 84. Fulgent Genetics Recent Developments
Table 85. Laboratory Corporation of America Holdings Company Information, Head Office, Market Area, and Industry Position
Table 86. Laboratory Corporation of America Holdings Company Profile and Main Business
Table 87. Laboratory Corporation of America Holdings Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
Table 88. Laboratory Corporation of America Holdings Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 89. Laboratory Corporation of America Holdings Recent Developments
Table 90. BGI Genomics Company Information, Head Office, Market Area, and Industry Position
Table 91. BGI Genomics Company Profile and Main Business
Table 92. BGI Genomics Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
Table 93. BGI Genomics Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 94. BGI Genomics Recent Developments
Table 95. Daan Gene Company Information, Head Office, Market Area, and Industry Position
Table 96. Daan Gene Company Profile and Main Business
Table 97. Daan Gene Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
Table 98. Daan Gene Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 99. Daan Gene Recent Developments
Table 100. Guangdong Hybribio Biotech Company Information, Head Office, Market Area, and Industry Position
Table 101. Guangdong Hybribio Biotech Company Profile and Main Business
Table 102. Guangdong Hybribio Biotech Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
Table 103. Guangdong Hybribio Biotech Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 104. Guangdong Hybribio Biotech Recent Developments
Table 105. Jiangsu Bioperfectus Technologies Company Information, Head Office, Market Area, and Industry Position
Table 106. Jiangsu Bioperfectus Technologies Company Profile and Main Business
Table 107. Jiangsu Bioperfectus Technologies Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
Table 108. Jiangsu Bioperfectus Technologies Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 109. Jiangsu Bioperfectus Technologies Recent Developments
Table 110. Maccura Biotechnology Company Information, Head Office, Market Area, and Industry Position
Table 111. Maccura Biotechnology Company Profile and Main Business
Table 112. Maccura Biotechnology Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
Table 113. Maccura Biotechnology Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 114. Maccura Biotechnology Recent Developments
Table 115. Guangzhou Wondfo Biotech Company Information, Head Office, Market Area, and Industry Position
Table 116. Guangzhou Wondfo Biotech Company Profile and Main Business
Table 117. Guangzhou Wondfo Biotech Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
Table 118. Guangzhou Wondfo Biotech Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 119. Guangzhou Wondfo Biotech Recent Developments
Table 120. GoBroad Healthcare Company Information, Head Office, Market Area, and Industry Position
Table 121. GoBroad Healthcare Company Profile and Main Business
Table 122. GoBroad Healthcare Clinical Reference Laboratory Molecular Diagnostic Services Models, Specifications, and Application
Table 123. GoBroad Healthcare Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Gross Margin, US$ Million, 2020-2025
Table 124. GoBroad Healthcare Recent Developments
List of Figures
Figure 1. Clinical Reference Laboratory Molecular Diagnostic Services Picture
Figure 2. Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Forecast, 2020-2031, US$ Million
Figure 3. China Clinical Reference Laboratory Molecular Diagnostic Services Revenue and Forecast, 2020-2031, US$ Million
Figure 4. By Revenue, China Clinical Reference Laboratory Molecular Diagnostic Services Share of Global Market, 2020-2031
Figure 5. Global Clinical Reference Laboratory Molecular Diagnostic Services Key Participants, Market Share, 2023 VS 2024 VS 2025
Figure 6. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024
Figure 7. China Clinical Reference Laboratory Molecular Diagnostic Services Key Participants, Market Share, 2023 VS 2024 VS 2025
Figure 8. China Clinical Reference Laboratory Molecular Diagnostic Services Key Participants, Market Share, 2024
Figure 9. China Clinical Reference Laboratory Molecular Diagnostic Services Revenue, Domestic VS Import Products, Proportion of China Local Companies and Foreign Companies, 2020-2031
Figure 10. Clinical Reference Laboratory Molecular Diagnostic Services Industry Chain
Figure 11. Nucleic Acid Amplification Testing
Figure 12. Nucleic Acid Hybridization Testing
Figure 13. Gene Sequencing
Figure 14. Gene Chip Technology
Figure 15. Others
Figure 16. by Type, Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue, 2020-2031, US$ Million
Figure 17. by Type, Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2020-2031
Figure 18. Disease Diagnosis
Figure 19. Drug Development
Figure 20. Personalized Healthcare
Figure 21. Medicolegal Expertise
Figure 22. Others
Figure 23. by Application, Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue, 2020-2031, US$ Million
Figure 24. by Application, Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2020-2031
Figure 25. By Region, Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue, 2020-2031, US$ Million
Figure 26. By Region, Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2020-2031
Figure 27. North America Clinical Reference Laboratory Molecular Diagnostic Services Revenue & Forecasts, 2020-2031, US$ Million
Figure 28. By Country, North America Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024
Figure 29. Europe Clinical Reference Laboratory Molecular Diagnostic Services Revenue & Forecasts, 2020-2031, US$ Million
Figure 30. By Country, Europe Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024
Figure 31. Asia Pacific Clinical Reference Laboratory Molecular Diagnostic Services Revenue & Forecasts, 2020-2031, US$ Million
Figure 32. By Country/Region, Asia Pacific Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024
Figure 33. South America Clinical Reference Laboratory Molecular Diagnostic Services Revenue & Forecasts, 2020-2031, US$ Million
Figure 34. By Country, South America Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024
Figure 35. Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Revenue & Forecasts, 2020-2031, US$ Million
Figure 36. United States Clinical Reference Laboratory Molecular Diagnostic Services Revenue, 2020-2031, US$ Million
Figure 37. By Company, United States Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024
Figure 38. by Type, United States Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
Figure 39. by Application, United States Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
Figure 40. Europe Clinical Reference Laboratory Molecular Diagnostic Services Revenue, 2020-2031, US$ Million
Figure 41. By Company, Europe Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024
Figure 42. by Type, Europe Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
Figure 43. by Application, Europe Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
Figure 44. China Clinical Reference Laboratory Molecular Diagnostic Services Revenue, 2020-2031, US$ Million
Figure 45. By Company, China Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024
Figure 46. by Type, China Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
Figure 47. by Application, China Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
Figure 48. Japan Clinical Reference Laboratory Molecular Diagnostic Services Revenue, 2020-2031, US$ Million
Figure 49. By Company, Japan Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024
Figure 50. by Type, Japan Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
Figure 51. by Application, Japan Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
Figure 52. South Korea Clinical Reference Laboratory Molecular Diagnostic Services Revenue, 2020-2031, US$ Million
Figure 53. By Company, South Korea Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024
Figure 54. by Type, South Korea Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
Figure 55. by Application, South Korea Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
Figure 56. Southeast Asia Clinical Reference Laboratory Molecular Diagnostic Services Revenue, 2020-2031, US$ Million
Figure 57. By Company, Southeast Asia Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024
Figure 58. by Type, Southeast Asia Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
Figure 59. by Application, Southeast Asia Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
Figure 60. India Clinical Reference Laboratory Molecular Diagnostic Services Revenue, 2020-2031, US$ Million
Figure 61. By Company, India Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024
Figure 62. by Type, India Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
Figure 63. by Application, India Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
Figure 64. Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Revenue, 2020-2031, US$ Million
Figure 65. By Company, Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024
Figure 66. by Type, Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
Figure 67. by Application, Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share, 2024 VS 2031
Figure 68. Research Methodology
Figure 69. Breakdown of Primary Interviews
Figure 70. Bottom-up Approaches
Figure 71. Top-down Approaches
Research Methodology:
Clinical Reference Laboratory Molecular Diagnostic Services Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|